Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Marimed (MRMD) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Marimed (MRMD) over the last 15 years, with Q3 2025 value amounting to -$2.9 million.

  • Marimed's Net Income towards Common Stockholders fell 19707.07% to -$2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$17.6 million, marking a year-over-year decrease of 2541.25%. This contributed to the annual value of -$12.2 million for FY2024, which is 2398.33% up from last year.
  • Latest data reveals that Marimed reported Net Income towards Common Stockholders of -$2.9 million as of Q3 2025, which was down 19707.07% from -$1.3 million recorded in Q2 2025.
  • Marimed's Net Income towards Common Stockholders' 5-year high stood at $7.6 million during Q2 2021, with a 5-year trough of -$10.1 million in Q4 2023.
  • Over the past 5 years, Marimed's median Net Income towards Common Stockholders value was -$990000.0 (recorded in 2024), while the average stood at -$859842.1.
  • Per our database at Business Quant, Marimed's Net Income towards Common Stockholders soared by 76498.31% in 2021 and then tumbled by 31950.46% in 2025.
  • Over the past 5 years, Marimed's Net Income towards Common Stockholders (Quarter) stood at -$6.4 million in 2021, then surged by 174.13% to $4.7 million in 2022, then crashed by 313.5% to -$10.1 million in 2023, then rose by 21.08% to -$8.0 million in 2024, then skyrocketed by 63.25% to -$2.9 million in 2025.
  • Its last three reported values are -$2.9 million in Q3 2025, -$1.3 million for Q2 2025, and -$5.4 million during Q1 2025.